KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA)
CUSIP: 48669G303
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
- Shares outstanding
- 11,387,333
- Total 13F shares
- 2,479,478
- Share change
- +2,151,403
- Total reported value
- $17,070,899
- Price per share
- $6.89
- Number of holders
- 22
- Value change
- +$14,797,378
- Number of buys
- 13
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 48669G303?
CUSIP 48669G303 identifies KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 48669G303:
Top shareholders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
|
— |
5.1%
|
580,754
|
$3,740,056 | $0 | 31 Dec 2025 | |
| Dauntless Investment Group, LLC |
13F
13D/G
|
Company |
0%
from 13D/G
|
118,139
|
$851,782 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
24,000
|
$173,040 | — | 30 Sep 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.09%
|
10,700
|
$77,147 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
3,543
|
$25,545 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
639
|
$4,677 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
591
|
$4,324 | — | 30 Sep 2025 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
200
|
$1,442 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
200
|
$1,442 | — | 30 Sep 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
52
|
$375 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
10
|
$74 | — | 30 Sep 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
1
|
$8 | — | 30 Sep 2025 | |
| Alumni Capital LP |
13D/G
|
— |
10%
|
178,591
|
— | $0 | 31 Jul 2025 |
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) as of Q4 2025
As of 31 Dec 2025,
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,479,478 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., Stonepine Capital Management, LLC, Bleichroeder LP, Velan Capital Investment Management LP, Point72 Asset Management, L.P., Empery Asset Management, LP, CORSAIR CAPITAL MANAGEMENT, L.P., ROYAL BANK OF CANADA, Westside Investment Management, Inc., and BARCLAYS PLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
11
Q4 2025 holders
22
Holder diff
11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.